Studies have provided preclinical proof of concept that induction of bergamot may improve the phenotypical and morphological features of NASH along with reduction in adipose tissue inflammation and inflammatory cytokines, IL-6 and TNFα, hypoadiponectinemia, insulin resistance and dyslipidemia (Musolino et al., 2020). The gene discussed is IL6; the disease is Insulin resistance.